Co-authored article
Two perspectives on the future of brain organoids
Constant Beroulle (Newfund) x Petra Szeszula (Brainzell)
Back to home
Newfund and Brainzell joined forces to combine venture capital and scientific expertise in a co-authored article exploring how brain organoids can accelerate neuroscience innovation and the development of new therapies.
Following discussions around Brainzell and Newfund's investment activity in the brain organoid space, Constant invited Petra to join the BrainTech Alliance. This led to a co-authored article combining Newfund's unique investment-driven perspective on the global brain organoid ecosystem - built through its dedicated BrainTech investment thesis and extensive international deal flow - with Brainzell's scientific and entrepreneurial expertise in brain organoids. The objective was to provide the BrainTech and TechBio communities with practical, expert-led insights into brain organoids as a powerful tool to accelerate neuroscience innovation and bring new therapies to market.